Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

Topiramate for migraine prevention

Toparimate (Topamax®) is growing in popularity for the prevention of migraine. This is a licensed indication but current Clinical Knowledge Summary (CKS) recommendations suggest that this drug should only be initiated by specialists.

A recent assessment conducted by the National Prescribing Service in Australia has supported this second line position and also provides some useful information regarding efficacy and side effects.

The NPS assessment concludes:

  • Topiramate is an alternative migraine-prevention option for adults unable to take beta blockers or pizotifen
  • Around 50% of patients using topiramate experienced paraesthesia
  • Cognitive effects (cognitive slowing, language difficulties and difficulties with memory and concentration) are common (6% to 7%) and lead to treatment withdrawal in up to 3% of patients
  • There is no evidence that topiramate is more effective than other migraine-prevention drugs

Action: Based upon these conclusions and the information provided in the CKS on Migraine, topiramate should be restricted to use in patients where beta-blockers and amitriptyline have proven to be ineffective or are not tolerated.

Share 'Topiramate for migraine prevention' on Email Share 'Topiramate for migraine prevention' on Delicious Share 'Topiramate for migraine prevention' on Digg Share 'Topiramate for migraine prevention' on Facebook Share 'Topiramate for migraine prevention' on Google+ Share 'Topiramate for migraine prevention' on reddit Share 'Topiramate for migraine prevention' on StumbleUpon Share 'Topiramate for migraine prevention' on Twitter

atomic-wealth

No Comments to “Topiramate for migraine prevention”

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.
Akismet has protected Prescribing Advice for GPs from 789,520 spam comments.

atomic-wealth
fond-illness
summer